找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Congenital Bleeding Disorders; Diagnosis and Manage Akbar Dorgalaleh Book 20181st edition Springer International Publishing AG, part of Spr

[复制链接]
楼主: 召唤
发表于 2025-3-28 17:02:33 | 显示全部楼层
Bernard-Soulier Syndromemore specific laboratory studies such as aggregometry assays, flow cytometry, and molecular analysis can help to precise and timely diagnosis of disorder. BSS treatment includes supportive cares as well as specific treatment of bleeding episodes.
发表于 2025-3-28 19:17:38 | 显示全部楼层
发表于 2025-3-29 01:34:13 | 显示全部楼层
发表于 2025-3-29 04:24:55 | 显示全部楼层
Hemophilia Bcurring in ~1% of patients remains as a challenge of replacement therapy that can cause infused FIX concentrate to be less efficient. Gene therapy is the only definitive curative option, but some time will pass before it becomes available as a routine treatment choice.
发表于 2025-3-29 07:42:31 | 显示全部楼层
Book 20181st editionces for disease-related morbidity and mortality. The authors are acknowledged specialists in the field from across the world who have particular expertise in the disorder that they discuss. The book will be of value to hematologists, oncologists, pediatricians, laboratory specialists and technicians, general physicians, and trainees. .
发表于 2025-3-29 11:28:45 | 显示全部楼层
enges that they pose.Provides up-to-date guidance on use of This book describes in detail the clinical presentation, diagnosis, and management of a wide range of congenital bleeding disorders. It will assist readers in overcoming the significant challenges involved in clinical and laboratory diagnos
发表于 2025-3-29 18:31:24 | 显示全部楼层
Daniela Meneses Sala,Corina Rueda-Borrerothe more frequent cross-reactive material negative (CRM−) and the rare cross-reactive material positive (CRM+). Different therapeutic choices are available including fresh frozen plasma (FFP) and FXI concentrates that can provoke inhibitor formation, while recombinant FVII can be used for such patients.
发表于 2025-3-29 21:38:28 | 显示全部楼层
Book 20181st editionaders in overcoming the significant challenges involved in clinical and laboratory diagnosis and in providing effective clinical care that makes optimal use of new products, including recombinant factor. .concentrate. The coverage ranges from hemophilia A and B and von Willebrand disease to rare ble
发表于 2025-3-30 01:06:33 | 显示全部楼层
发表于 2025-3-30 04:18:19 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-7-6 12:48
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表